Avoiding immunity and apoptosis: Manipulation of the host environment by herpes simplex virus and Epstein-Barr virus

Seminars in Virology

Volumn 8, Issue 5, 1998, Pages 361-368

  Hill, Ann B ^a   Masucci, Maria G ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; APOPTOSIS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HOST RESISTANCE; IMMUNE RESPONSE; LATENT VIRUS INFECTION; NONHUMAN; PERSISTENT VIRUS INFECTION; REVIEW; VIRUS REACTIVATION; VIRUS REPLICATION;

HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; SIMPLEXVIRUS;

EID: 0031831341     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1997.0144     Document Type: Article

References (33)

1. Rock K. L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A. L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761-771.
2. Michalek M. T., Grant E. P., Gramm C., Goldberg A. L., Rock K. L. A role for ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature. 363:1993;552-554.
3. Lupas A., Koster A. J., Baumeister W. Structural features of 26S and 20S proteasomes. Enzyme Protein. 47:1993;252-273.
4. Cardozo C. Catalytic components of the bovine pituitary multicatalytic proteinase complex (proteasome). Enzyme Protein. 47:1993;296-305.
5. Tanaka K., Tamura T., Yoshimura T., Ichihara A. Proteasomes: Protein and gene structure. New Biol. 4:1992;173-187.
6. Seemüller E., Lupas A., Stock D., Löwe J., Huber R., Baumeister W. Proteasome fromThermoplasma acidophylum:a threonine protease. Science. 268:1995;579-582.
7. Gaczinska M., Rock K., Goldberg A. L. γ-Interferon and the expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature. 365:1993;264-267.
8. Driscoll J., Brown M. G., Finley D., Monaco J. J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature. 365:1993;262-264.
9. Heemels M.-T., Ploegh H. L. Generation, translocation and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:1995;463-491.
10. Sadasivan B., Lehner P. J., Ortmann B., Spies T., Cresswell P. Roles for calreticulin and a novel glycoprotein, Tapasin, in the interaction of MHC class I molecules with TAP. Immunity. 5:1996;103-114.
11. +T lymphocytes. Cell. 77:1994;525-535.
12. Hill A. B., Jugovic P., York I., Russ I., Bennink J., Yewdell J., Ploegh H. L., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-415.
13. Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P. M., Tampe R., Peterson P. A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature. 375:1995;415-418.
14. Tomazin R., Hill A. B., Jugovic P., York I., van Endert P., Ploegh H. L., Andrews D. W., Johnson D. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15:1996;3256-3266.
15. Ahn K., Meyer T. H., Uebel S., Sempe P., Djaballah H., Yang Y., Peterson P. A., Fruh K., Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15:1996;3247-3255.
16. Galocha B., Hill A. B., Cook R., Barnett B., Nolan A., Raimondi A., McGeoch D., Ploegh H. L. Identification of the active site of ICP47, an herpes simplex virus encoded inhibitor of TAP. J. Exp. Med. 185:1997;1565-1572.
17. Kieff E. Epstein-Barr virus and its replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 2343-2396.
18. Rickinson A. B., Kieff E. Epstein-Barr virus. Fields B. N., Knipe D. M., Howley P. M. Virology. 1996;2397-2446 Lippincott-Raven, Philadelphia.
19. Masucci M. G., Ernberg I. Epstein-Barr virus: Adaptation to a life within the immune system. Trends Microbiol. 2:1994;125-130.
20. Rickinson A. B., Rowe M., Hart I. J., Yao Q. Y., Henderson L. E., Rabin H., Epstein M. A. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell. Immunol. 87:1984;646-658.
21. von Knebel Doeberitz M., Bornkamm G. W., zur Hausen H. Establishment of spontaneously outgrowing lymphoblastoid cell lines with cyclosporin A. Med. Microbiol. Immunol. 172:1983;87-99.
22. Miyashita E. M., Yang B., Lam K. M., Crawford D. H., Thorley-Lawson D. A. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 80:1995;593-601.
23. Chen F., Zou J. Z., di Renzo L., Winberg G., Hu L. F., Klein E., Klein G., Ernberg I. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:1995;3752-3758.
24. Tierney R. J., Steven N., Young L. S., Rickinson A. B. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:1994;7374-7385.
25. Qu L., Rowe D. T. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66:1992;3715-3724.
26. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P. M., Klein G., Kurilla M. H., Masucci M. G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375:1995;685-688.
27. Levitskaya J., Sharipo A., Leontchiks A., Masucci M. G. Inhibition of ubiquitin-proteasome dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen (EBNA)1. Proc. Natl. Acad. Sci. USA. 94:1997;12616-12621.
28. Lee S. P., Thomas W. A., Murray R. J., Khanim F., Kaur S., Young L. S., Rowe M., Kurilla M., Rickinson A. B. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 67:1993;7428-7435.
29. Frisan T., Zhang Q.-J., Levitskaya J., Coram M., Kurilla M. G., Masucci M. G. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. Int. J. Cancer. 68:1996;251-258.
30. Austin P. J., Flemington E., Yandava C. N., Strominger J. S., Speck S. H. Complex transcription of the Epstein-Barr virus BamHI fragment H right-ward open reading frame (BHRF1) in latently and lytically infected B lymphocytes. Proc. Natl. Acad. Sci. USA. 85:1988;3678-3682.
31. McCarthy N. J., Hazlewood S. A., Huen D. S., Rickinson A. B., Williams G. T. The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs. Adv. Exp. Med. Biol. 406:1996;83-97.
32. Henderson S., Rowe M., Gregory C. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein-1 protects B cells from programmed cell death. Cell. 65:1991;1071-1115.
33. Miller W. E., Earp H. S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 69:1995;4390-4398.